Cargando…
Insulin expressing hepatocytes not destroyed in transgenic NOD mice
BACKGROUND: The liver has been suggested as a suitable target organ for gene therapy of Type 1 diabetes. However, the fundamental issue whether insulin-secreting hepatocytes in vivo will be destroyed by the autoimmune processes that kill pancreatic β cells has not been fully addressed. It is possibl...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544947/ https://www.ncbi.nlm.nih.gov/pubmed/15679918 http://dx.doi.org/10.1186/1740-2557-1-3 |